跳至主要内容
临床试验/ISRCTN14741769
ISRCTN14741769已完成4 期

Effect of 8 weeks oral pentaerithrityltetranitrate on endothelial dysfunction in patients with coronary artery disease: a prospective, randomized, double-blind, placebo-controlled, monocentric clinical trial of phase IV

Johannes Gutenberg University of Mainz (Germany)0 个研究点目标入组 80 人开始时间: 2007年6月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

2010 results in https://www.ncbi.nlm.nih.gov/pubmed/19957087 (added 07/01/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men or women > 35 and < 80 years of age
  • 2. Documented clinically stable CAD with stable angina pectoris
  • 3. Ability of subject to understand the character and individual consequences of the clinical trial
  • 4. Written informed consent must be available before enrollment in the trial
  • 5. For women with childbearing potential, adequate contraception (oral contraceptives or intrauterine devices) is required

排除标准

  • 1. Clinical signs of congestive heart failure or left ventricular ejection fraction <30% (as demonstrated within the last 1 year by echocardiography, Left Ventricular [LV] angiography, Magnetic Resonance Imaging [MRI] or radionuclide ventriculography, respectively)
  • 2. Uncontrolled hypertension (blood pressure >180/110mmHg) or hypotension (systolic blood pressure <110 mmHg)
  • 3. Initiation of any of the following medications within the last 8 weeks: aspirin, statins, calcium antagonists, Angiotensin Converting Enzyme (ACE)-inhibitors or AT1 receptor blockers, hormone replacement therapy. Individuals who take any of these drugs longer than 8 weeks can be included in this trial.
  • 4. Use of Phosphodiesterase-5-inhibitors (Viagra®, Revatio®, Cialis®, Levitra®), dihydroergotamine and nitrates i.e. isosorbidemononitrate, isosorbidedinitrate, nitroglycerin, pentaerithrityltetranitrate or molsidomin within the last two weeks.
  • 5. Hemodynamically significant aortic or mitral stenosis or hypertrophic obstructive cardiomyopathy (as demonstrated within the last year by echocardiography, invasive right/ left heart catherterization or MRI, respectively)
  • 6. Renal dysfunction (plasma creatinine [men: > 2.0 mg/dl, women: > 1.8 mg/dl])
  • 7. Known hepatic disease or elevation of serum transaminases or gGT > 3 x Upper Limit of Normal range (ULN)
  • 8. White Blood Cells (WBC) >16.000 or platelet count >500.000/µl or <75.000/µl
  • 9. Clinically overt hyperthyreodism
  • 10. Pregnancy and lactation
  • 11. Known intolerance to organic nitrates
  • 12. Known lactose intolerance
  • 13. History of hypersensitivity to the investigational medicinal product or to any drug with similar chemical structure or to any excipient present in the pharmaceutical form of the investigational medicinal product
  • 14. Other significant laboratory abnormalities that the investigator feels may compromise the patient's safety by participation in the study
  • 15. In other clinical trials and observation period of competing trials, respectively

研究者

发起方
Johannes Gutenberg University of Mainz (Germany)

相似试验

进行中(未招募)
不适用
Effect of 8 weeks oral Pentaerithrityltetranitrate on endothelial dysfunction in patients with coronary artery disease: A prospective, randomized, double-blind, placebo-controlled, monocentric clinical trial of phase IV - PENTAWomen or men >35 and < 80 years of age with documented, clinically stable coronary artery disease with stable angina pectoris from the heart catheter register, II. Med. Klinik, Johannes Gutenberg-University Mainz.MedDRA version: 9.1Level: LLTClassification code 10049194Term: Stable angina pectorisMedDRA version: 9.1Level: LLTClassification code 10011093Term: Coronary atherosclerosis
EUCTR2006-004533-15-DEJohannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel80
已完成
不适用
Ocular effect of TRPM8 agonist in patients with dry eye diseaseDry eye is a disorder of the tear film due to tear deficiency or excessive evaporation, which causes damage to the interpalpebral ocular surface and is associated with symptoms of ocular discomfort.Eye DiseasesOther disorders of lacrimal gland
ISRCTN24802609Chonnam National University Medical School and Hospital60
进行中(未招募)
不适用
Estudio para evaluar el efecto de Teriparatida comparado con Risedronato en el dolor de espalda de las mujeres postmenopausicas con fracturas vertebrales osteoporóticas”The Effect of Teriparatide Compared with Risedronate on Back Pain in Postmenopausal Women with Osteoporotic Vertebral Fractures - GHCY
EUCTR2005-005258-29-ESilly S.A.1,638
已完成
不适用
Clinical comparison of bioglass air abrasion vs tungsten carbide bur
ISRCTN20110108King's College London (UK)25
已完成
不适用
Ectopic activation of TRPM8 with a newly-developed agonist relieves dry-eye symptomsEye DiseasesOther disorders of lacrimal glandDry eye
ISRCTN13359367Chonnam National University Medical School and Hospital40